For example, the expression of miR-J1-5p decreases with the progression of CRC [17], and microRNA (miR)-216b levels are significantly downregulated in CRC cells treated with anti-EGFR therapy [18]. The gene discussed is EGFR; the disease is colorectal carcinoma.